Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3764507011 | Caplacizumab (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3764508018 | Caplacizumab | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 1125141000172119 | caplacizumab | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Belgian module (core metadata concept) |
| 1190291000172116 | caplacizumab | nl | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Belgian module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Caplacizumab (substance) | Has disposition (attribute) | Platelet aggregation inhibitor (disposition) | true | Inferred relationship | Some | ||
| Caplacizumab (substance) | Is a | Platelet aggregation inhibitor | true | Inferred relationship | Some | ||
| Caplacizumab (substance) | Is a | Monoclonal antibody | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Caplacizumab-containing product | Has active ingredient | True | Caplacizumab (substance) | Inferred relationship | Some | 1 |
| Product containing only caplacizumab (medicinal product) | Has active ingredient | True | Caplacizumab (substance) | Inferred relationship | Some | 1 |
| Caplacizumab-containing product in parenteral dose form | Has active ingredient | True | Caplacizumab (substance) | Inferred relationship | Some | 1 |
| Caplacizumab only product in parenteral dose form | Has active ingredient | True | Caplacizumab (substance) | Inferred relationship | Some | 1 |
Reference Sets
Belgian subset for AllergyIntolerance, causative agent, drug
FHIR